Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22613567 | 0.99 | TSHR (0.33) | TSHRS1PR1SGPL1CYP2D6L3MBTL1 | |
| SCHEMBL1631865 | 0.99 | TSHR (0.33) | TSHRS1PR1SGPL1CYP2D6L3MBTL1 | |
| SCHEMBL9896132 | 0.96 | S1PR1 (0.33) | TSHRS1PR1SGPL1CYP2D6L3MBTL1 | |
| SCHEMBL22613591 | 0.95 | S1PR1 (0.33) | TSHRS1PR1SGPL1CYP2D6L3MBTL1 | |
| SCHEMBL9896958 | 0.95 | S1PR1 (0.33) | TSHRS1PR1SGPL1CYP2D6L3MBTL1 | |
| SCHEMBL21359780 | 0.90 | CYP2D6 (0.31) | S1PR1SGPL1CYP2D6 | |
| SCHEMBL26128843 | 0.89 | ALDH1A1 (0.38) | S1PR1SGPL1RECQLALDH1A1SMN1; SMN2 | |
| Potassium Ion SCHEMBL29661212 | 0.88 | TSHR (0.34) | TSHRS1PR1SGPL1CYP2D6 | |
| SCHEMBL1631869 | 0.87 | TSHR (0.33) | TSHRS1PR1SGPL1CYP2D6 | |
| SCHEMBL26131918 | 0.85 | SMN1; SMN2 (0.37) | S1PR1SGPL1RECQLALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3529815-B1 | SOLID ELECTROLYTIC CAPACITOR COMPRISING A SILANE AGENT BETWEEN THE ANODE AND THE CONDUCTIVE POLYMER | KYOCERA AVX COMPONENTS CORP (US) | 2026-05-06 | — | — | EP | claimed |
| US-11955294-B2 | Solid electrolytic capacitor containing an intrinsically conductive polymer | KYOCERA AVX Components Corporation (US) | 2024-04-09 | — | — | US | claimed |
| US-11935708-B2 | Solid electrolytic capacitor with improved reliability | KEMET ELECTRONICS CORPORATION (US) | 2024-03-19 | — | — | US | claimed |
| EP-4293692-A1 | SOLID ELECTROLYTIC CAPACITOR WITH IMPROVED RELIABILITY | Kemet Electronics Corporation (US) | 2023-12-20 | — | — | EP | claimed |
| US-11791106-B2 | Solid electrolytic capacitor containing polyaniline | KYOCERA AVX Components Corporation (US) | 2023-10-17 | — | — | US | claimed |
| US-11694851-B2 | Capacitors with improved power cycling | KEMET ELECTRONICS CORPORATION (US) | 2023-07-04 | — | — | US | claimed |
| US-11676770-B2 | Electrolytic capacitor having a higher cap recovery and lower ESR | KEMET ELECTRONICS CORPORATION (US) | 2023-06-13 | — | — | US | claimed |
| CN-115124698-B | Potassium ion sensor and preparation method thereof | 苏州中星医疗技术有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-112585707-B | Method of forming electrolytic capacitors with higher CAP recovery and lower ESR | 凯米特电子公司 | 2023-02-21 | — | — | CN | claimed |
| CN-114974900-A | Capacitor with improved power cycle | 凯米特电子公司 | 2022-08-30 | — | — | CN | claimed |
| US-20130078701-A1 | DEVICE COMPRISING A CONDUCTIVE SURFACE AND A CONDUCTIVE POLYMER FOR ADHESION OF CELLS AND TISSUE | OBOE IPR AB (SE) | 2013-03-28 | — | — | US | claimed |
| EP-2556153-A2 | A DEVICE COMPRSING A CONDUCTIVE SURFACE AND A CONDUCTIVE POLYMER FOR ADHESION OF CELLS AND TISSUE | OBOE IPR AB (SE) | 2013-02-13 | — | — | EP | claimed |
| US-7147936-B2 | Layer configuration with improved stability to sunlight exposure | AGFA GEVAERT (BE) | 2006-12-12 | — | — | US | claimed |
| US-7056600-B2 | Layer configuration comprising an electron-blocking element | AGFA GEVAERT (BE) | 2006-06-06 | — | — | US | claimed |
| EP-1551921-B1 | LAYER CONFIGURATION WITH IMPROVED STABILITY TO SUNLIGHT EXPOSURE | AGFA GEVAERT (BE) | 2006-03-29 | — | — | EP | claimed |
| US-6977390-B2 | Layer configuration comprising an electron-blocking element | AGFA GEVAERT (BE) | 2005-12-20 | — | — | US | claimed |
| WO-2004019347-A1 | LAYER CONFIGURATION COMPRISING AN ELECTRON-BLOCKING ELEMENT | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | WO | claimed |
| US-20040044214-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | US | claimed |
| US-20040043895-A1 | Layer configuration with improved stability to sunlight exposure | AGFA-GEVAERT (BE) | 2004-03-04 | — | — | US | claimed |
| US-20040036067-A1 | Layer configuration comprising an electron-blocking element | AGFA-GEVAERT (BE) | 2004-02-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044214-A1 | Layer configuration comprising an electron-blocking element | PCBP1, RER1, SCO2 | TSHR 3511/4885S1PR1 749/4885SGPL1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.